Literature DB >> 12612431

Three cycloartane glycosides from Cimicifuga rhizome and their immunosuppressive activities in mouse allogeneic mixed lymphocyte reaction.

Makiko Nishida1, Hitoshi Yoshimitsu, Toshihiro Nohara.   

Abstract

One known (1) and two new cycloartane triglycosides, 20S,22R,23S,24R-16beta,23;22,25-diepoxy-cycloartane-3beta,23,24-triol 3-O-beta-D-glucopyranosyl-(1-->2)-beta-D-glucopyranosyl-(1-->2)-beta-D-xylopyranoside (2) and 20S,22R,23S,24R-16beta,23;22,25-diepoxy-cycloartane-3beta,23,24-triol 3-O-(6-O-trans-isoferuloyl-beta-D-glucopyranosyl)-(1-->2)-beta-D-glucopyranosyl-(1-->2)-beta-D-xylopyranoside (3), were isolated from a commercial Cimicifuga Rhizome. Their structures were determined by two dimensional (2D) NMR spectroscopic analysis and chemical evidence. These compounds suppressed the proliferation of lymphocytes in mouse allogeneic mixed lymphocyte reaction.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12612431     DOI: 10.1248/cpb.51.354

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  4 in total

1.  Effects of (20S*,24R*)-epoxy-9,19-cyclolanstane-3β,12β,16β,25-pentaol-3-O-β-D-xylopyranoside extracted from rhizoma Beesia on immunoregulation and anti-inflammation.

Authors:  Xian-Zhe Dong; Dai-Hong Guo; Ping Liu; Li-Hua Mu; Xiao-Yue Ge; Hong-Jie Li; Xiao-Li Zheng
Journal:  Inflammation       Date:  2014-02       Impact factor: 4.092

2.  Immunomodulatory effects of black cohosh (Actaea racemosa) extract in female B6C3F1/N mice.

Authors:  Matthew J Smith; Dori R Germolec; Rachel P Frawley; Kimber L White
Journal:  Toxicology       Date:  2013-04-06       Impact factor: 4.221

Review 3.  Photochemistry and pharmacology of 9, 19-cyclolanostane glycosides isolated from genus Cimicifuga.

Authors:  Yang Su; Wen-Cheng Chi; Lun Wu; Qiu-Hong Wang; Hai-Xue Kuang
Journal:  Chin J Nat Med       Date:  2016-10-31

4.  Serum proteomic, peptidomic and metabolomic profiles in myasthenia gravis patients during treatment with Qiangji Jianli Fang.

Authors:  Chunmei Wang; Yonghai Lu; Zhixi Chen; Xiaobin Liu; Huangquan Lin; Hui Zhao; Jinyan Chen; Yiuwa Kwan; Saiming Ngai
Journal:  Chin Med       Date:  2012-07-28       Impact factor: 5.455

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.